VEGF-C, human recombinant protein
Vascular Endothelial Growth Factor-C, VEGFC
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q6FH59 |
---|---|
Calculated MW | 15-16 kDa |
Gene ID | 7424 |
---|---|
Gene Symbol | VEGFC |
Other Names | Vascular Endothelial Growth Factor-C, VEGFC, Flt4 ligand |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥90% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Results | >200 ng/ml |
Target/Specificity | VEGF-C |
Application Notes | Reconstitute in 0.1% acetic acid to a concentration of 0.1-1.0 mg/ml |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The recombinant VEGF-C (Vascular Endothelial Growth Factor-C) is a 125 amino acid protein that lacks the N-terminal signal peptide (from T103 to R227 of Gene Bank U58111). Human VEGF-C exhibits about 85% homology with murine VEGF-C.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.